menu
    • menu

    Company profile for Scandion Oncology

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy. Half of all cancer patients fail chemotherapy. This resistance increases mortality and represents a major burden for the health care system. With approximately 18 million new cancer cases being diagnosed each year, a new treatment that can help overco...
    Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy. Half of all cancer patients fail chemotherapy. This resistance increases mortality and represents a major burden for the health care system. With approximately 18 million new cancer cases being diagnosed each year, a new treatment that can help overcome chemotherapy resistance could have immense business potential. Scandion Oncology is working to develop treatments that will re-sensitize cancer cells to chemotherapy within metastatic colon and breast cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Scandion OncologyDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Symbion Fruebjergvej 3 DK 2100 København
    Telephone
    Telephone
    +45 26144708
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://scandiononcology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/scandion-oncology/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scandion flunks phase 2 test just a month after exec departures
    Scandion flunks phase 2 test just a month after exec departures

    30 Sep 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/scandion-flunks-part-2-its-phase-2-trial-due-low-tumor-reduction-rate

    Max Bayer FIERCEBIOTECH
    30 Sep 2022
    Share Share
    Scandion Oncology receives approval for initiating the CORIST part 2 trial
    Scandion Oncology receives approval for initiating the CORIST part 2 trial

    06 Sep 2021

    // CISION

    https://news.cision.com/scandion-oncology-a-s/r/scandion-oncology-receives-approval-for-initiating-the-corist-part-2-trial,c3410221

    CISION
    06 Sep 2021
    Share Share
    Scandion Oncology receives German trial approval for PANTAX Ib study
    Scandion Oncology receives German trial approval for PANTAX Ib study

    27 Aug 2021

    // CISION

    https://news.cision.com/scandion-oncology-a-s/r/scandion-oncology-receives-german-trial-approval-for-pantax-ib-study,c3404242

    CISION
    27 Aug 2021
    Share Share
    Scandion Oncology announces results from the next evaluable chemo-resistant
    Scandion Oncology announces results from the next evaluable chemo-resistant

    21 Aug 2020

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/scandion-oncology-announces-results-from-the-next-evaluable-chemo-resistant-1598628935.pdf

    PRESS RELEASE
    21 Aug 2020
    Share Share
    Scandion Oncology drug SCO-101 potentiates the effect of chemotherapy
    Scandion Oncology drug SCO-101 potentiates the effect of chemotherapy

    31 Jul 2020

    // CISION

    https://news.cision.com/scandion-oncology-a-s/r/scandion-oncology-drug-sco-101-potentiates-the-effect-of-chemotherapy-in-the-first-cohort-of-patient,c3162348

    CISION
    31 Jul 2020
    Share Share
    Clinical development plans for SCO-101
    Clinical development plans for SCO-101

    23 Mar 2020

    // CISION

    https://news.cision.com/scandion-oncology-a-s/r/clinical-development-plans-for-sco-101,c3066414

    CISION
    23 Mar 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search